Fructosamine-3-Kinase as a Potential Treatment Option for Age-Related Macular Degeneration

Fructosamine-3-Kinase as a Potential Treatment Option for Age-Related Macular Degeneration

Age-related macular degeneration is the leading cause of blindness in the developed world. Since advanced glycation end products (AGEs) are implicated in the pathogenesis of AMD through various lines of evidence, we investigated the potential of fructosamine-3-kinase (FN3K) in the disruption of reti...

Full description

Bibliographic Details
Main Authors: Sander De Bruyne, Caroline Vandenbroecke, Henk Vrielinck, Samira Khelifi, Olivier De Wever, Ken Bracke, Manon Huizing, Nezahat Boston, Jonas Himpe, Marijn Speeckaert, Anne Vral, Jo Van Dorpe, Elisabeth Van Aken, Joris R. Delanghe
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
age-related macular degeneration
eye diseases
fructosamine-3-kinase
glycation end products
advanced
retinal drusen
Online Access:https://www.mdpi.com/2077-0383/9/9/2869

Similar Items

Similar Items